These include focused libraries of small-molecule compounds with potential biological activity towards certain diseases (such as Anti-Cancer Compound Library, Anti-Diabetic Compound Library, Anti-Cardiovascular Disease Compound Library, etc.).
Cat No. | product name | ||
---|---|---|---|
L9810 | Anti-Fibrosis Compound Library | A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS; | 1180 compounds |
L8400 | Hematonosis Compound Library | A unique collection of 514 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); | 514 compounds |
L2194 | Anti-Colorectal Cancer Compound Library | 1545 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening. | 1545 compounds |
L2620 | Anti-Neurodegenerative Disease Compound Library | A unique collection of 2154 compounds related to neurodegenerative diseases can be used for HTS or HCS; | 2154 compounds |
L4660 | Anti-Nervous System Disease Library | Well-chosen 1246 compounds with unique structures targeting nervous system; | 1246 compounds |
L5400 | Anti-Cardiovascular Disease Compound Library | A unique collection of 1408 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | 1408 compounds |
L2100 | Anti-Cancer Compound Library | A unique collection of 7234 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | 7234 compounds |
L4700 | Immunology/Inflammation Compound Library | A unique collection of 4720 anti-inflammation compounds effective for high throughput screening and high content screening. | 4720 compounds |
L2196 | Anti-Ovarian Cancer Compound Library | A unique collection of 1867 compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological study; | 1867 compounds |
L2152 | Targeted Therapy Drug Library | 119 tumor-targeted drugs that can be used for high-throughput and high-content screening. | 119 compounds |
L4710 | Nonsteroidal Anti-Inflammatory Compound Library | 530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening. | 530 compounds |
L2193 | Anti-Liver Cancer Compound Library | 1787 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies. | 1787 compounds |
L9840 | Anti-Alzheimer's Disease Compound Library | A unique collection of 986 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. | 986 compounds |
L5200 | Anti-Metabolism Disease Compound Library | A unique collection of 1544 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | 1544 compounds |
L9830 | Anti-Parkinson's Disease Compound Library | A unique collection of 857 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | 857 compounds |
L2170 | Immuno-Oncology Compound Library | A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening; | 449 compounds |
L8200 | Anti-Aging Compound Library | A unique collection of 3279 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | 3279 compounds |
L4520 | Anti-Bacterial Compound Library | A unique collection of 904 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | 904 compounds |
L4510 | Anti-Parasitic Compound Library | 419 well-chosen unique anti-parasitic small molecules; | 419 compounds |
L2190 | Anti-Lung Cancer Compound Library | A unique collection of 1702 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study; | 1702 compounds |
L2160 | Anti-Cancer Active Compound Library | A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | 3188 compounds |
L1800 | Anti-Infection Compound Library | A unique collection of 2938 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | 2938 compounds |
L2195 | Anti-Prostate Cancer Compound Library | 2070 compounds associated with prostate cancer that can be used for high-throughput and high-content screening. | 2070 compounds |
L7100 | Anti-Obesity Compound Library | A unique collection of 2247 anti-obesity compounds for high throughput and high content screening; | 2247 compounds |
L2180 | Anti-Cancer Compound Library Plus | Well-chosen 1468 anti-tumor compounds with unique structures; | 1468 compounds |
L2110 | Anti-Cancer Approved Drug Library | A unique collection of 1779 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); | 1779 compounds |
L7110 | Anti-Hypertension Compound Library | 678 hypertension-related small molecules for high-throughput and high-content screening. | 678 compounds |
L1710 | Anti-COVID-19 Compound Library | A unique collection of 1133 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents; | 1133 compounds |
L2151 | Chemotherapy Drug Library | 48 Chemotherapeutic drugs that can be used for high-throughput and high-content screening. | 48 compounds |
L2120 | Anti-Cancer Clinical Compound Library | A unique collection of 2545 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); | 2545 compounds |
L1900 | Anti-Diabetic Compound Library | A unique collection of 683 diabetes related compounds; | 683 compounds |
L9860 | Antidepressant Compound Library | 1163 compounds associated with depression that can be used for high-throughput and high-content screening | 1163 compounds |
L2192 | Anti-Pancreatic Cancer Compound Library | A unique collection of 2238 pancreatic cancer related compounds can be used in HTS and HCS; | 2238 compounds |
L2191 | Anti-Breast Cancer Compound Library | A unique collection of 1939 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study; | 1939 compounds |
L2130 | Anti-Cancer Metabolism Compound Library | A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | 1268 compounds |
L2140 | Cancer Cell Differentiation Compound Library | A unique collection of 406 cancer cell differentiation inducing compounds for high throughput and high content screening; | 406 compounds |
L2150 | Anti-Cancer Drug Library | A unique collection of 3080 anticancer drugs for high throughput screening (HTS) and high content screening (HCS); | 3080 compounds |
L4500 | Anti-Fungal Compound Library | A unique collection of 252 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation. | 252 compounds |
L1700 | Anti-Viral Compound Library | A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening; | 1040 compounds |